摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[4-cyclopentylmethyloxy-3-(2-methylbenzothiazol-5-yl)phenyl]propionic acid | 590413-90-4

中文名称
——
中文别名
——
英文名称
3-[4-cyclopentylmethyloxy-3-(2-methylbenzothiazol-5-yl)phenyl]propionic acid
英文别名
3-[4-(Cyclopentylmethoxy)-3-(2-methyl-1,3-benzothiazol-5-yl)phenyl]propanoic acid
3-[4-cyclopentylmethyloxy-3-(2-methylbenzothiazol-5-yl)phenyl]propionic acid化学式
CAS
590413-90-4
化学式
C23H25NO3S
mdl
——
分子量
395.522
InChiKey
VHDQXMXLSGPSCV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6
  • 重原子数:
    28
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    87.7
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • Substituted phenylalkanoic acid derivatives and use thereof
    申请人:——
    公开号:US20040044258A1
    公开(公告)日:2004-03-04
    A compound represented by the formula (I) or a salt thereof: 1 wherein n represents an integer of 1 to 3, R represents an alkyl group having 3 to 8 carbon atoms, a group represented by the following formula: R 1 (CH 2 ) k — (wherein k represents 0 or an integer of 1 to 3; R 1 represents a saturated cyclic alkyl group having 3 to 7 carbon atoms or a saturated condensed cyclic alkyl group having 6 to 8 carbon atoms, and the group R 1 may be substituted with a lower alkyl group having 1 to 4 carbon atoms) and the like, and Ar represents a condensed bicyclic group such as naphthalen-1-yl group, which has suppressing action on prostaglandin and leukotriene production and is useful for prophylactic and/or therapeutic treatment of various inflammatory diseases and the like caused by these lipid mediators.
    化合物的化学式为(I)或其盐: 其中n表示1到3的整数,R表示具有3到8个碳原子的烷基基团,由以下化学式表示的基团:R1(CH2)k—(其中k表示0或1到3的整数;R1表示具有3到7个碳原子的饱和环烷基基团或具有6到8个碳原子的饱和紧凑环烷基基团,基团R1可以被具有1到4个碳原子的较低烷基基团取代)等,Ar表示如-1-基团等的紧凑双环基团,具有对前列腺素白三烯生成的抑制作用,对由这些脂质介质引起的各种炎症性疾病等的预防和/或治疗治疗有用。
  • [EN] SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF<br/>[FR] DERIVE D'ACIDE ARYLALCANOIQUE SUBSTITUE ET SON UTILISATION
    申请人:ASAHI KASEI PHARMA CORP
    公开号:WO2005016862A1
    公开(公告)日:2005-02-24
    A compound represented by the formula (I)[In the formula, Link represents a saturated or unsaturated straight hydrocarbon chain having 1 to 3 carbon atoms, C2 to C6 in the aromatic ring (E) independently represent a ring-constituting carbon atom, one of the ring-constituting carbon atoms may be replaced with V, V represents nitrogen atom, or carbon atom substituted with Zx, Zx represents a saturated alkyl group having 1 to 4 carbon atoms and the like, Rs represents -D-Rx etc., D represents a single bond, oxygen atom and the like, Rx represents a saturated alkyl group having 3 to 8 carbon atoms and the like, AR represents a partially unsaturated or completely unsaturated condensed bicyclic carbon ring or a heterocyclic ring, and Y represents hydrogen atom, a lower alkyl group having 1 to 4 carbon atoms and the like] or a salt thereof. A compound having prostaglandin production-suppressing action and leukotriene production-suppressing action is provided.
    化合物的化学式为(I)。在该式中,Link代表一个由1至3个碳原子组成的饱和或不饱和直链烃链,芳环(E)中的C2至C6独立代表构成环的碳原子,构成环的碳原子中的一个可以被V取代,V代表氮原子,或者被Zx取代的碳原子,Zx代表由1至4个碳原子组成的饱和烷基基团等,Rs代表-D-Rx等,D代表单键、氧原子等,Rx代表由3至8个碳原子组成的饱和烷基基团等,AR代表部分不饱和或完全不饱和的紧凑双环碳环或杂环,Y代表氢原子、由1至4个碳原子组成的低烷基基团等,或其盐。提供了一种具有抑制前列腺素产生和抑制白三烯产生作用的化合物。
  • Substituted arylalkanoic acid derivatives and use thereof
    申请人:Shoda Motoshi
    公开号:US20070213333A1
    公开(公告)日:2007-09-13
    A compound represented by the formula (I): [In the formula, Link represents a saturated or unsaturated straight hydrocarbon chain having 1 to 3 carbon atoms, C 2 to C 6 in the aromatic ring (E) independently represent a ring-constituting carbon atom, one of the ring-constituting carbon atoms may be replaced with V, V represents nitrogen atom, or carbon atom substituted with Zx, Zx represents a saturated alkyl group having 1 to 4 carbon atoms and the like, Rs represents -D-Rx etc., D represents a single bond, oxygen atom and the like, Rx represents a saturated alkyl group having 3 to 8 carbon atoms and the like, AR represents a partially unsaturated or completely unsaturated condensed bicyclic carbon ring or a heterocyclic ring, and Y represents hydrogen atom, a lower alkyl group having 1 to 4 carbon atoms and the like] or a salt thereof. A compound having prostaglandin production-suppressing action and leukotriene production-suppressing action is provided.
    化合物的化学式为(I):[在公式中,Link代表饱和或不饱和的直链碳氢链,其具有1至3个碳原子,C2至C6在芳环(E)中独立地表示构成环的碳原子,构成环的碳原子中的一个可以被V取代,V代表氮原子,或被Zx取代的碳原子,Zx代表饱和的烷基基团,其具有1至4个碳原子等,Rs代表-D-Rx等,D代表单键,氧原子等,Rx代表饱和的烷基基团,其具有3至8个碳原子等,AR代表部分不饱和或完全不饱和的紧凑双环碳环或杂环,Y代表氢原子,具有1至4个碳原子的低烷基基团等]或其盐。提供了一种具有前列腺素生成抑制作用和白三烯生成抑制作用的化合物。
  • SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF
    申请人:Asahi Kasei Pharma Corporation
    公开号:EP1477472A1
    公开(公告)日:2004-11-17
    A compound represented by the formula (I) or a salt thereof wherein n represents an integer of 1 to 3, R represents an alkyl group having 3 to 8 carbon atoms, a group represented by the following formula: R1(CH2)k- (wherein k represents 0 or an integer of 1 to 3; R1 represents a saturated cyclic alkyl group having 3 to 7 carbon atoms or a saturated condensed cyclic alkyl group having 6 to 8 carbon atoms, and the group R1 may be substituted with a lower alkyl group having 1 to 4 carbon atoms) and the like, and Ar represents a condensed bicyclic group such as naphthalen-1-yl group, which has suppressing action on prostaglandin and leukotriene production and is useful for prophylactic and/or therapeutic treatment of various inflammatory diseases and the like caused by these lipid mediators.
    由式(I)代表的化合物或其盐 其中 n 代表 1 至 3 的整数,R 代表具有 3 至 8 个碳原子的烷基,由下式代表的基团:R1(CH2)k- (其中 k 代表 0 或 1 至 3 的整数;R1 代表具有 3 至 7 个碳原子的饱和环状烷基或具有 6 至 8 个碳原子的饱和缩合环状烷基,该基团 R1 可被具有 1 至 4 个碳原子的低级烷基取代)等,Ar 代表缩合双环基团,例如-1-基团,该基团具有抑制前列腺素白三烯生成的作用,可用于预防和/或治疗由这些脂质介质引起的各种炎症等。
  • SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF
    申请人:Asahi Kasei Pharma Corporation
    公开号:EP1660427A1
    公开(公告)日:2006-05-31
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-